TZIELD Trademark

Trademark Overview

On Tuesday, March 16, 2021, a trademark application was filed for TZIELD with the United States Patent and Trademark Office. The USPTO has given the TZIELD trademark a serial number of 90581915. The federal status of this trademark filing is REGISTERED as of Tuesday, March 28, 2023. This trademark is owned by Provention Bio, Inc.. The TZIELD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention, delay and treatment of diabetes
tzield

General Information

Serial Number90581915
Word MarkTZIELD
Filing DateTuesday, March 16, 2021
Status700 - REGISTERED
Status DateTuesday, March 28, 2023
Registration Number7013217
Registration DateTuesday, March 28, 2023
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 30, 2021

Trademark Statements

Description of MarkThe mark consists of the literal element "Tzield" and four curved bands positioned above the letter "i". The bands originate at the same point and fan out upwards and to the right over the letter "e".
Goods and ServicesPharmaceutical preparations for the prevention, delay and treatment of diabetes

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 16, 2021
Primary Code005
First Use Anywhere DateThursday, December 1, 2022
First Use In Commerce DateThursday, December 1, 2022

Trademark Owner History

Party NameProvention Bio, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRed Bank, NJ 07701
Party NameProvention Bio, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRed Bank, NJ 07701
Party NameProvention Bio, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRed Bank, NJ 07701

Trademark Events

Event DateEvent Description
Friday, March 19, 2021NEW APPLICATION ENTERED
Wednesday, June 16, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 17, 2021NOTICE OF DESIGN SEARCH CODE E-MAILED
Saturday, October 16, 2021ASSIGNED TO EXAMINER
Monday, October 25, 2021EXAMINERS AMENDMENT -WRITTEN
Monday, October 25, 2021EXAMINERS AMENDMENT E-MAILED
Monday, October 25, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Monday, October 25, 2021EXAMINER'S AMENDMENT ENTERED
Monday, October 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 10, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 30, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 30, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 25, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 22, 2022SOU TEAS EXTENSION RECEIVED
Friday, July 22, 2022SOU EXTENSION 1 FILED
Friday, July 22, 2022SOU EXTENSION 1 GRANTED
Tuesday, July 26, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2023TEAS STATEMENT OF USE RECEIVED
Monday, January 23, 2023USE AMENDMENT FILED
Friday, February 17, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, February 17, 2023STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 21, 2023ASSIGNED TO EXAMINER
Tuesday, February 21, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, February 22, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, March 28, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 28, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, May 28, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 28, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 28, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

Related Keywords

tzield treatment diabetes delay prevention preparations pharmaceutical